The multi-cancer marker, rs6983267, located at region 3 of chromosome 8q24, is associated with prostate cancer in Greek patients but does not contribute to the aggressiveness of the disease

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 2, 2012, Pages 379-385

  Papanikolopoulou, Amalia ^a   Landt, Olfert ^b   Ntoumas, Konstantinos ^c   Bolomitis, Stefanos ^c   Tyritzis, Stavros I ^d   Constantinides, Constantinos ^d   Drakoulis, Nikolaos ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b TIB MOLBIOL   (Germany)

^c IASO GENERAL HOSPITAL   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

8q24; cancer marker; prostate cancer; rs6983267

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; CANCER FAMILY; CANCER SCREENING; CANCER STAGING; CASE CONTROL STUDY; CHROMOSOME 8Q; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ETHNIC GROUP; GENOTYPE; GLEASON SCORE; GREECE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CHROMOSOMES, HUMAN, PAIR 8; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HUMANS; MALE; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860536594     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.2011.778     Document Type: Article

References (29)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92. (Pubitemid 46359643)
2. Crawford ED. Epidemiology of prostate cancer. Urology 2003;62:3-12. (Pubitemid 38050194)
3. Eckersberger E, Finkelstein J, Sadri H, Margreiter M, Taneja SS, Lepor H, et al. Screening for prostate cancer: a review of the ERSPC and PLCO trials. Rev Urol 2009;11:127-33.
4. Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, et al. A combined genomewide linkage scan of 1, 233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005;77:219-29. (Pubitemid 41022705)
5. Liu H, Wang B, Han C. Meta-analysis of genome-wide and replication association studies on prostate cancer. Prostate 2011;71:209-24.
6. Xu Z, Bensen JT, Smith GJ, Mohler JL, Taylor JA. GWAS SNP replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP). Prostate 2011;71:881-91.
7. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007;39:631-7. (Pubitemid 46676102)
8. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, et al. Genome-wide association study of prostate cancer identi-fies a second risk locus at 8q24. Nat Genet 2007;39:645-9. (Pubitemid 46676108)
9. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007;39:638-44. (Pubitemid 46676106)
10. Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, et al. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst 2007;99:1525-33. (Pubitemid 351767236)
11. Robbins C, Torres JB, Hooker S, Bonilla C, Hernandez W, Candreva A, et al. Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res 2007;17:1717-22. (Pubitemid 351359995)
12. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008;358:910-9. (Pubitemid 351397090)
13. Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, et al., UK Genetic Prostate Cancer Study Collaborators/British. Association of Urological Surgeons'Section of Oncology, UK Prostate testing for cancer and Treatment study (ProtecT Study) collaborators. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 2009; 41: 1058-60.
14. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, et al. A common variant associated with pros tate cancer in European and African populations. Nat Genet 2006;38:652-8. (Pubitemid 43927306)
15. Yeager M, Xiao N, Hayes RB, Bouffard P, Desany B, Burdett L, et al. Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers. Hum Genet 2008;124:161-70.
16. Haiman CA, Le Marchand L, Yamamato J, Stram DO, Sheng X, Kolonel LN, et al. A common genetic risk factor for colorectal and prostate cancer. Nat Genet 2007;39:954-6. (Pubitemid 47185184)
17. Wokolorczyk D, Gliniewicz B, Sikorski A, Zlowocka E, Masojc B, Debniak T, et al. A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res 2008;68: 9982-6.
18. Park SL, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, et al. Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites. Cancer Epidemiol Biomarkers Prev 2008;17:3193-202.
19. Tewari A, Johnson CC, Divine G, Crawford ED, Gamito EJ, Demers R, et al. Long-term survival probability in men with clinically localised prostate cancer: a case-control, propensity modelling study stratified by race, age, treatment and comorbidi-ties. J Urol 2004;171:1513-9. (Pubitemid 38365408)
20. Stamatiou K, Alevizos A, Agapitos E, Sofras F. Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study. Prostate 2006;66:1319-28. (Pubitemid 44389158)
21. Lange EM, Salinas CA, Zuhlke KA, Ray AM, Wang Y, Lu Y, et al. Early onset prostate cancer has a significant genetic component. Prostate 2011 May 2. doi: 10.1002/pros.21414. [Epub ahead of print]
22. Cornu JN, Drouin S, Cancel-Tassin G, Bigot P, Azzouzi AR, Koutlidis N, et al. Impact of genotyping on outcome of pros-tatic biopsies: a multicentre prospective study. Mol Med 2011 Feb 4. doi: 10.2119/molmed.2010.00205. [Epub ahead of print]
23. Beebe-Dimmer JL, Levin AM, Ray AM, Zuhlke KA, Machiela MJ, Halstead-Nussloch BA, et al. Chromosome 8q24 markers: risk of early-onset and familial prostate cancer. Int J Cancer 2008;122:2876-9. (Pubitemid 351631393)
24. Cheng I, Plummer SJ, Jorgenson E, Liu X, Rybicki BA, Casey G, et al. 8q24 and prostate cancer: association with advanced disease and meta analysis. Eur J Hum Genet 2008;16: 496-505. (Pubitemid 351420383)
25. Cussenot O, Azzouzi AR, Bantsimba-Malanda G, Gaffory C, Mangin P, Cormier L, et al. Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer. Clin Cancer Res 2008;14:5635-9.
26. Pal P, Xi H, Guha S, Sun G, Helfand BT, Meeks JJ, et al. Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry. Prostate 2009;69:1548-56.
27. Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, Kivioja T, et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signalling. Nat Genet 2009;41:885-90.
28. Dai J, Hall CL, Escara-Wilke J, Mizokami A, Keller JM, Keller ET. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Cancer Res 2008;68:5785-94.
29. Kastler S, Honold L, Luedeke M, Kuefer R, Möller P, Hoegel J, et al. POU5F1P1, a putative cancer susceptibility gene, is over-expressed in prostatic carcinoma. Prostate 2010;70:666-74.